Literature DB >> 33161020

History of ectonucleotidases and their role in purinergic signaling.

Herbert Zimmermann1.   

Abstract

Ectonucleotidases are key for purinergic signaling. They control the duration of activity of purinergic receptor agonists. At the same time, they produce hydrolysis products as additional ligands of purinergic receptors. Due to the considerable diversity of enzymes, purinergic receptor ligands and purinergic receptors, deciphering the impact of extracellular purinergic receptor control has become a challenge. The first group of enzymes described were the alkaline phosphatases - at the time not as nucleotide-metabolizing but as nonspecific phosphatases. Enzymes now referred to as nucleoside triphosphate diphosphohydrolases and ecto-5'-nucleotidase were the first and only nucleotide-specific ectonucleotidases identified. And they were the first group of enzymes related to purinergic signaling. Additional research brought to light a surprising number of ectoenzymes with broad substrate specificity, which can also hydrolyze nucleotides. This short overview traces the development of the field and briefly highlights important results and benefits for therapies of human diseases achieved within nearly a century of investigations.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alkaline phosphatase; Ecto-5′-nucleotidase; Ecto-nucleotide pyrophosphatase/phosphodiesterase; Ectonucleotidase; History; Nucleoside triphosphate diphosphohydrolase

Year:  2020        PMID: 33161020     DOI: 10.1016/j.bcp.2020.114322

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  15 in total

1.  Effect of Thiazolidin-4-one Against Lipopolysaccharide-Induced Oxidative Damage, and Alterations in Adenine Nucleotide Hydrolysis and Acetylcholinesterase Activity in Cultured Astrocytes.

Authors:  Fernando Lopez Alvez; Natália Pontes Bona; Nathalia Stark Pedra; Daniel Schuch da Silva; Wilson João Cunico; Francieli Moro Stefanello; Cinthia Melazzo de Andrade; Mayara Sandrielly Pereira Soares; Roselia Maria Spanevello
Journal:  Cell Mol Neurobiol       Date:  2022-01-15       Impact factor: 5.046

Review 2.  The purinergic signalling and inflammation in the pathogenesis and progression of diabetes: key factors and therapeutic targets.

Authors:  André Campos de Lima; Lucas Macedo Chaves; Samantha Nuncio Prestes; Aline Mânica; Andreia Machado Cardoso
Journal:  Inflamm Res       Date:  2022-06-01       Impact factor: 6.986

3.  Agonist-Dependent Coupling of the Promiscuous Adenosine A2B Receptor to Gα Protein Subunits.

Authors:  Jan Hendrik Voss; Andhika B Mahardhika; Asuka Inoue; Christa E Müller
Journal:  ACS Pharmacol Transl Sci       Date:  2022-05-03

4.  Mechanosensitive Hydrolysis of ATP and ADP in Lamina Propria of the Murine Bladder by Membrane-Bound and Soluble Nucleotidases.

Authors:  Mafalda S L Aresta Branco; Alejandro Gutierrez Cruz; Jacob Dayton; Brian A Perrino; Violeta N Mutafova-Yambolieva
Journal:  Front Physiol       Date:  2022-06-16       Impact factor: 4.755

5.  Optimized HPLC method to elucidate the complex purinergic signaling dynamics that regulate ATP, ADP, AMP, and adenosine levels in human blood.

Authors:  Carola Ledderose; Eleftheria-Angeliki Valsami; Wolfgang G Junger
Journal:  Purinergic Signal       Date:  2022-02-07       Impact factor: 3.950

Review 6.  Expanding the repertoire of methanocarba nucleosides from purinergic signaling to diverse targets.

Authors:  Kenneth A Jacobson; Veronica Salmaso; R Rama Suresh; Dilip K Tosh
Journal:  RSC Med Chem       Date:  2021-07-13

Review 7.  E-NTPDases: Possible Roles on Host-Parasite Interactions and Therapeutic Opportunities.

Authors:  Lisvane Paes-Vieira; André Luiz Gomes-Vieira; José Roberto Meyer-Fernandes
Journal:  Front Cell Infect Microbiol       Date:  2021-11-09       Impact factor: 5.293

Review 8.  A novel definition and treatment of hyperinflammation in COVID-19 based on purinergic signalling.

Authors:  Djo Hasan; Atsuko Shono; Coenraad K van Kalken; Peter J van der Spek; Eric P Krenning; Toru Kotani
Journal:  Purinergic Signal       Date:  2021-11-10       Impact factor: 3.765

Review 9.  The elegant complexity of mammalian ecto-5'-nucleotidase (CD73).

Authors:  Karel P Alcedo; Jessica L Bowser; Natasha T Snider
Journal:  Trends Cell Biol       Date:  2021-06-08       Impact factor: 21.167

10.  Structure-activity relationships of pyrimidine nucleotides containing a 5'-α,β-methylene diphosphonate at the P2Y6 receptor.

Authors:  Paola Oliva; Mirko Scortichini; Clemens Dobelmann; Shanu Jain; Varun Gopinatth; Kiran S Toti; Ngan B Phung; Anna Junker; Kenneth A Jacobson
Journal:  Bioorg Med Chem Lett       Date:  2021-05-26       Impact factor: 2.940

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.